Molecular diagnostics firm Vermillion is relocating its corporate headquarters from Fremont, California to Austin, Texas. The company will continue its research and development, regulatory, and quality functions in California, with all other divisions moving to Texas.
"This move allows us to take advantage of Austin's strong talent pool and cost-effective environment to continue to build the company into a leading provider of novel, high-value diagnostic tests," said Gail S. Page, CEO and Chair of the Board of Directors of Vermillion. "Austin's central location also facilitates more efficient and effective interaction with our national sales force and our strategic partners on the East Coast, such as Quest Diagnostics and Johns Hopkins University, as well as our colleagues on the West Coast, such as PrecisionMed and Stanford University."
The company plans to complete the move by September 2010.Vermillion has diagnostic programs in oncology, hematology, cardiology, and women's health.